Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date:	January 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$26.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 2.86%
Avg Daily Range (30 D):	$0.74 | 2.12%
Avg Daily Range (90 D):	$0.71 | 2.23%

Institutional Daily Volume
Avg Daily Volume:	3.67M
Avg Daily Volume (30 D):	3.9M
Avg Daily Volume (90 D):	4.43M

Trade Size
Avg Trade Size (Sh.):	135
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	4,825
Avg Institutional Trade:	$4.5M
Avg Institutional Trade (30 D):	$7.37M
Avg Institutional Trade (90 D):	$6.71M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$12.84M
Avg Closing Trade (30 D):	$32.93M
Avg Closing Trade (90 D):	$30.28M
Avg Closing Volume:	829.99K

News

May 18, 2026 @ 5:00 PM Myasthenia Gravis Market Set to Surpass USD 16 Bil... Source: Delveinsight

Apr 15, 2026 @ 5:00 PM Generalized Myasthenia Gravis Market on the Brink ... Source: Delveinsight

Apr 2, 2026 @ 9:00 AM Priovant Expands Brepocitinib Development Program ... Source: Na

Mar 28, 2026 @ 7:00 PM New England Journal of Medicine Publishes Positive... Source: Priovant Therapeutics / Roivant Sciences

Mar 5, 2026 @ 7:42 PM 9 Biotech Stocks Trading Far Below Fair Value With... Source: David Wagner

Financials
	TTM	Q1 2027	Q4 2026
Basic EPS	$-.36	$-.26	$.45
Diluted EPS	$-.47	$-.26	$.34
Revenue	$7.53M	$1.44M	$2.52M
Gross Profit
Net Income / Loss	$-414.6M	$-290.61M	$355.74M
Operating Income / Loss	$-596.14M	$-365.99M	$415.24M
Cost of Revenue
Net Cash Flow	$8.67M	$-170.75M	$-59.1M
PE Ratio